Case number 1:22-cv-01233
Nexus Pharmaceuticals, Inc. v. Exela Pharma Sciences, LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 6, 2023 | 24 | NOTICE OF SERVICE of Nexus Pharmaceuticals, Inc.s First Set of Interrogatories to Defendant and First Set of Requests for Production of Documents and Things filed by Nexus Pharmaceuticals, Inc..(Farnan, Kelly) (Entered: 10/06/2023) (2) |
| Sep 27, 2023 | 23 | MOTION for Pro Hac Vice Appearance of Attorney Imron Aly, Kevin Nelson and Adam Diederich - filed by Nexus Pharmaceuticals, Inc.. (Farnan, Kelly) (Entered: 09/27/2023) (5) |
| Sep 26, 2023 | 22 | MOTION for Pro Hac Vice Appearance of Attorney Sarah E. Jack - filed by Exela Pharma Sciences, LLC. (McCann, Douglas) (Entered: 09/26/2023) (2) |
| Aug 23, 2023 | 21 | ANSWER to 20 Answer to Amended Complaint, Counterclaim by Nexus Pharmaceuticals, Inc..(Farnan, Kelly) (Entered: 08/23/2023) (7) |
| Aug 2, 2023 | 20 | ANSWER to Amended Complaint, re: 18 Amended Complaint with Jury Demand (Second), COUNTERCLAIM against Nexus Pharmaceuticals, Inc. by Exela Pharma Sciences, LLC.(McCann, Douglas) (Entered: 08/02/2023) (30) |
| Jul 19, 2023 | 19 | STIPULATION TO EXTEND TIME to File Responsive Pleading to August 2, 2023 - filed by Exela Pharma Sciences, LLC. (McCann, Douglas) (Entered: 07/19/2023) (2) |
| Jul 5, 2023 | 18 | Amended Complaint* (1) |
| Jul 5, 2023 | 18 | Second AMENDED COMPLAINT against Exela Pharma Sciences, LLC- filed by Nexus Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-C)(Farnan, Kelly) (Entered: 07/05/2023) (0) |
| Jun 13, 2023 | 17 | MEMORANDUM ORDER re 7 MOTION to Dismiss for Failure to State a Claim filed by Exela Pharma Sciences, LLC is GRANTED without prejudice. Signed by Judge Gregory B. Williams on 6/13/23. (ntl) (ntl). (Entered: 06/13/2023) (8) |
| Jan 13, 2023 | 16 | REQUEST for Oral Argument by Exela Pharma Sciences, LLC re 7 MOTION to Dismiss for Failure to State a Claim . (McCann, Douglas) (Entered: 01/13/2023) (1) |
| Jan 6, 2023 | 15 | REPLY BRIEF re 7 MOTION to Dismiss for Failure to State a Claim filed by Exela Pharma Sciences, LLC. (McCann, Douglas) (Entered: 01/06/2023) (14) |
| Dec 19, 2022 | 14 | STIPULATION TO EXTEND TIME for Defendant to file Reply in Support of Its Motion to Dismiss to January 6, 2023 - filed by Exela Pharma Sciences, LLC. (McCann, Douglas) (Entered: 12/19/2022) (2) |
| Dec 19, 2022 | 13 | ANSWERING BRIEF in Opposition re 7 MOTION to Dismiss for Failure to State a Claim filed by Nexus Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 12/27/2022. (Farnan, Kelly) (Entered: 12/19/2022) (19) |
| Dec 12, 2022 | 12 | ORDER re 11 Unopposed MOTION for Extension of Time to File Its Answering Brief in Opposition to the Motion to Dismiss filed by Nexus Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 12/12/22. (ntl) (Entered: 12/12/2022) (1) |
| Dec 9, 2022 | 11 | MOTION for Extension of Time to File Its Answering Brief in Opposition to the Motion to Dismiss - filed by Nexus Pharmaceuticals, Inc.. (Attachments: # 1 Text of Proposed Order Proposed Order)(Haynes, Christine) (Entered: 12/09/2022) (0) |
| Nov 21, 2022 | 7 | MOTION to Dismiss for Failure to State a Claim - filed by Exela Pharma Sciences, LLC. (Attachments: # 1 Text of [Proposed] Order)(McCann, Douglas) (Entered: 11/21/2022) (Main Document) (2) |
| Nov 21, 2022 | 8 | OPENING BRIEF in Support re 7 MOTION to Dismiss for Failure to State a Claim filed by Exela Pharma Sciences, LLC.Answering Brief/Response due date per Local Rules is 12/5/2022. (McCann, Douglas) (Entered: 11/21/2022) (16) |
| Nov 21, 2022 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Corrin N. Drakulich, Dexter S. Whitley and Deanna J. Reichel - filed by Exela Pharma Sciences, LLC. (McCann, Douglas) (Entered: 11/21/2022) (4) |
| Nov 21, 2022 | 10 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Exela PharmSci, Inc. for Exela Pharma Sciences, LLC filed by Exela Pharma Sciences, LLC. (McCann, Douglas) (Entered: 11/21/2022) (2) |
| Nov 21, 2022 | 7 | MOTION to Dismiss for Failure to State a Claim - filed by Exela Pharma Sciences, LLC. (Attachments: # 1 Text of [Proposed] Order)(McCann, Douglas) (Entered: 11/21/2022) (Text of [Proposed] Order) (1) |
| Oct 13, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [6] STIPULATION TO EXTEND TIME to Respond to Amended Complaint to November 21, 2022 filed by Exela Pharma Sciences, LLC. Signed by Judge Gregory B. Williams on 10/13/2022. (etg) |
| Oct 12, 2022 | 6 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Respond to Amended Complaint to November 21, 2022 - filed by Exela Pharma Sciences, LLC. (McCann, Douglas) |
| Oct 11, 2022 | 5 | Amended Complaint (Patent/Trademark Report Amended Nexus AO_120) (1) Docket Text: First AMENDED COMPLAINT against Exela Pharma Sciences, LLC- filed by Nexus Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit Exhibit A, # (2) Exhibit Exhibit B, # (3) Patent/Trademark Report Amended Nexus AO_120)(Farnan, Kelly) |
| Oct 11, 2022 | 5 | Amended Complaint (Exhibit Exhibit B) (28) Docket Text: First AMENDED COMPLAINT against Exela Pharma Sciences, LLC- filed by Nexus Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit Exhibit A, # (2) Exhibit Exhibit B, # (3) Patent/Trademark Report Amended Nexus AO_120)(Farnan, Kelly) |
| Oct 11, 2022 | 5 | Amended Complaint (Exhibit Exhibit A) (28) Docket Text: First AMENDED COMPLAINT against Exela Pharma Sciences, LLC- filed by Nexus Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit Exhibit A, # (2) Exhibit Exhibit B, # (3) Patent/Trademark Report Amended Nexus AO_120)(Farnan, Kelly) |
| Oct 11, 2022 | 5 | Amended Complaint (Main Document) (9) Docket Text: First AMENDED COMPLAINT against Exela Pharma Sciences, LLC- filed by Nexus Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit Exhibit A, # (2) Exhibit Exhibit B, # (3) Patent/Trademark Report Amended Nexus AO_120)(Farnan, Kelly) |
| Oct 11, 2022 | 5 | Amended Complaint* (1) |
| Sep 28, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) |
| Sep 21, 2022 | 4 | Summons Issued (2) Docket Text: Summons Issued as to Exela Pharma Sciences, LLC on 9/21/2022. (apk) |
| Sep 21, 2022 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,426,369 B2. (apk) |
| Sep 21, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Sep 21, 2022 | 1 | Complaint (Civil Cover Sheet) (2) Docket Text: COMPLAINT filed with Jury Demand against Exela Pharma Sciences, LLC ( Filing fee $ 402, receipt number ADEDC-3964597.) - filed by Nexus Pharmaceuticals, Inc. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(apk) |
| Sep 21, 2022 | 1 | Complaint (Exhibit A) (28) Docket Text: COMPLAINT filed with Jury Demand against Exela Pharma Sciences, LLC ( Filing fee $ 402, receipt number ADEDC-3964597.) - filed by Nexus Pharmaceuticals, Inc. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(apk) |
| Sep 21, 2022 | 1 | Complaint (Main Document) (7) Docket Text: COMPLAINT filed with Jury Demand against Exela Pharma Sciences, LLC ( Filing fee $ 402, receipt number ADEDC-3964597.) - filed by Nexus Pharmaceuticals, Inc. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(apk) |
| Sep 21, 2022 | 1 | Complaint* (1) |
